Travis Eisemann

606 citations
8 papers · 446 indexed · h-index 8

Impact in

  • Physiology top 10%
    • Calcium signaling and nucleotide metabolism
    • PARP inhibition in cancer therapy

Papers in

Travis Eisemann

8 papers receiving 442 citations

Peers

Travis Eisemann
Comparison fields: 5 of 65
  • Physiology 39
  • Oncology 222
  • Cell Biology 129
  • Molecular Biology 317
  • Immunology 72
Replace Beata Kuśmider with:
Beata Kuśmider Switzerland
Mandovi Chatterjee United States
Andreas Kniss Germany
Asher Castiel Israel
Cheryl L. Meyerkord United States
Stefan Kernstock Norway
Kang Zhu United Kingdom
Shichen Hu China
Gábor Mocsár Hungary
Nia Soetandyo United States
Travis Eisemann relative to Beata Kuśmider Switzerland Beata Kuśmider's profile →
Citations per field
00.5×1.5×2.0×
Beata Kuśmider · 1×
Citations per year

Countries citing papers authored by Travis Eisemann

Since Specialization
Citations

This map shows the geographic impact of Travis Eisemann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Travis Eisemann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Travis Eisemann more than expected).

Fields of papers citing papers by Travis Eisemann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Travis Eisemann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Travis Eisemann. The network helps show where Travis Eisemann may publish in the future.

Co-authors

The 25 scholars most cited alongside Travis Eisemann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Travis Eisemann Line = papers co-authored together Travis Eisemann links everyone, so they are left out of the graph.

All Works

8 of 8 papers shown
#Work
1 202010
2 202023
3 201920
4 201985
5 2018154
6 2018101
7 201644
8 20149

About Travis Eisemann

Travis Eisemann is a scholar working on Virology, Cell Biology, Oncology, Immunology and Molecular Biology, having authored 8 papers that have together received 446 indexed citations. Recurring topics across this work include PARP inhibition in cancer therapy (3 papers), DNA Repair Mechanisms (2 papers), Wnt/β-catenin signaling in development and cancer (2 papers), Cellular transport and secretion (2 papers), Lipid Membrane Structure and Behavior (2 papers), Toxin Mechanisms and Immunotoxins (2 papers), Cell death mechanisms and regulation (1 paper) and Retinal Development and Disorders (1 paper). The work is most often cited by research in Physiology (39 citations), Oncology (222 citations), Cell Biology (129 citations), Molecular Biology (317 citations) and Immunology (72 citations). Travis Eisemann has collaborated with scholars based in United States and Canada. Frequent co-authors include John M. Pascal, Marie-France Langelier, Amanda A. Riccio, Frederick M. Hughson, Junyi Jiao, Hong Qu, Yukun Wang, Yongli Zhang, Sarah A. Port and Richard W. Baker. Their work appears in journals such as eLife, Structure, Cellular and Molecular Life Sciences, Current Opinion in Structural Biology and Molecular Therapy — Methods & Clinical Development.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026